- Healthcare Professionals
- Research
- Clinical trials
- Elevate study
2024-07-30T00:00:00.000+10:00
Ongoing
Elevate Study
Elevate Study
Chronic Lymphocytic Leukaemia
A Multicentre, Open-label, Randomised, Phase IV Study to Investigate Acalabrutinib Monotherapy Compared to Investigator’s Choice of Treatment in Adults (> 18 Years) With Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment
A Multicentre, Open-label, Randomised, Phase IV Study to Investigate Acalabrutinib Monotherapy Compared to Investigator’s Choice of Treatment in Adults (> 18 Years) With Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment
Trial overview
Disease
Haematology
Topic
Diagnostics
Sponsor
Astra Zeneca
Description
A Multicentre, Open-label, Randomised, Phase IV Study to Investigate Acalabrutinib Monotherapy Compared to Investigator’s Choice of Treatment in Adults (> 18 Years) With Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment
Study details
To follow
Trial status
Opening August 2024
Location
Oxford
:::
Priniciple Investigator
Dr Toby Eyre
MBChB (Hons), DipMedEd, MRCP (UK), FRCPath (UK), MD (University of Newcastle)
Consultant Haematologist
Oxford
